News

ECOG-ACRIN ENDURANCE trial findings provide the first randomised evidence on the optimal duration of lenalidomide maintenance for patients with newly diagnosed multiple myeloma

New cancer drug shows promise in mesothelioma trial

Virtual, sustained smoking cessation program for cancer patients doubles quitting rate, clinical trial shows

Immune ecotypes may explain multiple myeloma outcomes missed by disease staging

Researchers link gut microbe to cancer-fighting immune response

Scientists uncover genetic clues from a tumour-prone reptile that could advance cancer research

“Acts as a ‘protective barrier’ in blood vessels, but disappears in tumour tissue”... Mussel protein opens a new path for pancreatic cancer treatment

Metabolic reprogramming of immune cells and metabolic intervention in cutaneous tumours

Artificial intelligence in oncology drug discovery: from target identification to therapeutic molecule generation

Combination treatment harnesses cellular recycling system to fight multiple myeloma

Genetically engineered Bifidobacterium shows potential for oral delivery of cancer vaccines

KRAS-targeting drugs show promise for rare appendix cancer